Peroxisome proliferator-activated receptor γ agonist suppresses mast cell maturation and induces apoptosis

Zhang,Yu; Li,Xinqian; Fang,Shengjian; Zhu,Zhenghua; Yao,Min; Ying,Liyun; Zhu,Liwei; Ma,Zhaoxin; Wang,Weihua

doi:10.3892/mmr.2017.6802

Peroxisome proliferator-activated receptor γ agonist suppresses mast cell maturation and induces apoptosis

Authors:
- Yu Zhang
- Xinqian Li
- Shengjian Fang
- Zhenghua Zhu
- Min Yao
- Liyun Ying
- Liwei Zhu
- Zhaoxin Ma
- Weihua Wang
View Affiliations

Affiliations: Department of Otolaryngology‑Head and Neck Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, P.R. China
Published online on: June 19, 2017 https://doi.org/10.3892/mmr.2017.6802
Pages: 1793-1800
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Peroxisome proliferator-activated receptor gamma (PPAR γ), is important in the immunoregulation of the allergic response. Mast cells are the most important inflammatory cells in immediate hypersensitivity and allergic diseases. However, there is limited information regarding the effects of PPAR γ on mast cell maturation. In the present study, mouse bone marrow‑derived mast cells (BMMCs) were cultured in interleukin (IL)‑3 and stem cell factor (SCF), in the presence or absence of the PPAR γ agonist, pioglitazone (PIO). The expression levels of the tyrosine kinase receptor CD117 and the high affinity IgE receptor FcεRI α, were assessed by flow cytometry, cell viability was assessed by Alamar‑Blue assay and histamine release was determined by measuring the activity of β‑hexosaminidase. IL‑3 and SCF are required for the development of mast cells in vitro. PIO dose‑dependently inhibited the expression of CD117 and FcεRI α, and the maturation of BMMCs. Treatment with PIO additionally inhibited the formation of granules and reduced the expression of β‑hexosaminidase. In addition, reverse transcription‑polymerase chain reaction analysis revealed that BMMCs treated with PIO expressed a lower level of mast cell protease (MCP)‑6 mRNA and PIO treatment enhanced the level of PPAR γ mRNA. Furthermore, PIO induced mast cell progenitor apoptosis. PPAR γ agonists may maintain mast cell homeostasis by inhibiting maturation of their precursors. The inhibitory effects of PPAR γ agonists include suppression of the activation of mast cells and a decrease in mast cell function in the inflammatory response. Therefore, PPAR γ agonists may serve as effective anti-inflammatory reagents in the treatment of allergic reactions.

View Figures

View References

1	Kersten S, Desvergne B and Wahli W: Roles of PPARs in health and disease. Nature. 405:421–424. 2000. View Article : Google Scholar : PubMed/NCBI
2	Tachibana M, Wada K, Katayama K, Kamisaki Y, Maeyama K, Kadowaki T, Blumberg RS and Nakajima A: Activation of peroxisome proliferator-activated receptor gamma suppresses mast cell maturation involved in allergic diseases. Allergy. 63:1136–1147. 2008. View Article : Google Scholar : PubMed/NCBI
3	Zhao Y, Huang Y, He J, Li C, Deng W, Ran X and Wang D: Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates airway inflammation by inhibiting the proliferation of effector T cells in a murine model of neutrophilic asthma. Immunol Lett. 157:9–15. 2014. View Article : Google Scholar : PubMed/NCBI
4	Marcone S, Haughton K, Simpson PJ, Belton O and Fitzgerald DJ: Milk-derived bioactive peptides inhibit human endothelial-monocyte interactions via PPAR-γ dependent regulation of NF-κB. J Inflamm (Lond). 12:12015. View Article : Google Scholar : PubMed/NCBI
5	Housley WJ, Adams CO, Vang AG, Brocke S, Nichols FC, LaCombe M, Rajan TV and Clark RB: Peroxisome proliferator-activated receptor gamma is required for CD4⁺ T cell-mediated lymphopenia-associated autoimmunity. J Immunol. 187:4161–4169. 2011. View Article : Google Scholar : PubMed/NCBI
6	Kim SH, Hong JH and Lee YC: Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13 and IL-17 in a mouse model of allergic asthma. Eur J Pharmacol. 701:131–143. 2013. View Article : Google Scholar : PubMed/NCBI
7	Wang W, Zhu Z, Zhu B and Ma Z: Peroxisome proliferator-activated receptor-gamma agonist induces regulatory T cells in a murine model of allergic rhinitis. Otolaryngol Head Neck Surg. 144:506–513. 2011. View Article : Google Scholar : PubMed/NCBI
8	Meng Y, Chen C, Tian C, Du J and Li HH: Angiotensin II-induced Egr-1 expression is suppressed by peroxisome proliferator-activated receptor-γ ligand 15d-PGJ2 in macrophages. Cell Physiol Biochem. 35:689–698. 2015. View Article : Google Scholar : PubMed/NCBI
9	Maeyama K, Emi M and Tachibana M: Nuclear receptors as targets for drug development: Peroxisome proliferator-activated receptor gamma in mast cells: Its roles in proliferation and differentiation. J Pharmacol Sci. 97:190–194. 2005. View Article : Google Scholar : PubMed/NCBI
10	Sugiyama H, Nonaka T, Kishimoto T, Komoriya K, Tsuji K and Nakahata T: Peroxisome proliferator-activated receptors are expressed in mouse bone marrow-derived mast cells. FEBS Lett. 467:259–262. 2000. View Article : Google Scholar : PubMed/NCBI
11	Spencer M, Yang L, Adu A, Finlin BS, Zhu B, Shipp LR, Rasouli N, Peterson CA and Kern PA: Pioglitazone treatment reduces adipose tissue inflammation through reduction of mast cell and macrophage number and by improving vascularity. PLoS One. 9:e1021902014. View Article : Google Scholar : PubMed/NCBI
12	Sly LM, Kalesnikoff J, Lam V, Wong D, Song C, Omeis S, Chan K, Lee CW, Siraganian RP, Rivera J and Krystal G: IgE-induced mast cell survival requires the prolonged generation of reactive oxygen species. J Immunol. 181:3850–3860. 2008. View Article : Google Scholar : PubMed/NCBI
13	Okayama Y and Kawakami T: Development, migration, and survival of mast cells. Immunol Res. 34:97–115. 2006. View Article : Google Scholar : PubMed/NCBI
14	Ma P, Mali RS, Munugalavadla V, Krishnan S, Ramdas B, Sims E, Martin H, Ghosh J, Li S, Chan RJ, et al: The PI3K pathway drives the maturation of mast cells via microphthalmia transcription factor. Blood. 118:3459–3469. 2011. View Article : Google Scholar : PubMed/NCBI
15	Wada K, Nakajima A, Katayama K, Kudo C, Shibuya A, Kubota N, Terauchi Y, Tachibana M, Miyoshi H, Kamisaki Y, et al: Peroxisome proliferator-activated receptor gamma-mediated regulation of neural stem cell proliferation and differentiation. J Biol Chem. 281:12673–12681. 2006. View Article : Google Scholar : PubMed/NCBI
16	Suzuki K and Verma IM: Phosphorylation of SNAP-23 by IkappaB kinase 2 regulates mast cell degranulation. Cell. 134:485–495. 2008. View Article : Google Scholar : PubMed/NCBI
17	Kashyap M, Bailey DP, Gomez G, Rivera J, Huff TF and Ryan JJ: TGF-beta1 inhibits late-stage mast cell maturation. Exp Hematol. 33:1281–1291. 2005. View Article : Google Scholar : PubMed/NCBI
18	Lantz CS and Huff TF: Murine KIT⁺ lineage- bone marrow progenitors express Fc gamma-RII but do not express Fc epsilon-RI until mast cell granule formation. J Immunol. 154:355–362. 1995.PubMed/NCBI
19	Cui Y, Dahlin JS, Feinstein R, Bankova LG, Xing W, Shin K, Gurish MF and Hallgren J: Mouse mast cell protease-6 and MHC are involved in the development of experimental asthma. J Immunol. 193:4783–4789. 2014. View Article : Google Scholar : PubMed/NCBI
20	Vangansewinkel T, Geurts N, Quanten K, Nelissen S, Lemmens S, Geboes L, Dooley D, Vidal PM, Pejler G and Hendrix S: Mast cells promote scar remodeling and functional recovery after spinal cord injury via mouse mast cell protease 6. FASEB J. 30:2040–2057. 2016. View Article : Google Scholar : PubMed/NCBI
21	Wang W, Zhu Z, Zhu B and Ma Z: Pioglitazone attenuates allergic inflammation and induces production of regulatory T lymphocytes. Am J Rhinol Allergy. 24:454–458. 2010. View Article : Google Scholar : PubMed/NCBI
22	Gurish MF and Austen KF: Developmental origin and functional specialization of mast cell subsets. Immunity. 37:25–33. 2012. View Article : Google Scholar : PubMed/NCBI
23	Rao KN and Brown MA: Mast cells: Multifaceted immune cells with diverse roles in health and disease. Ann N Y Acad Sci. 1143:83–104. 2008. View Article : Google Scholar : PubMed/NCBI
24	Chen CC, Grimbaldeston MA, Tsai M, Weissman IL and Galli SJ: Identification of mast cell progenitors in adult mice. Proc Natl Acad Sci USA. 102:11408–11413. 2005. View Article : Google Scholar : PubMed/NCBI
25	Kitamura Y, Oboki K and Ito A: Molecular mechanisms of mast cell development. Immunol Allergy Clin North Am. 26:387–405; v. 2006. View Article : Google Scholar : PubMed/NCBI
26	Saito H: Culture of human mast cells from hemopoietic progenitors. Methods Mol Biol. 315:113–122. 2006.PubMed/NCBI
27	Succar J, Douaiher J, Lancerotto L, Li Q, Yamaguchi R, Younan G, Pejler G and Orgill DP: The role of mouse mast cell proteases in the proliferative phase of wound healing in microdeformational wound therapy. Plast Reconstr Surg. 134:459–467. 2014. View Article : Google Scholar : PubMed/NCBI
28	Metcalfe DD, Baram D and Mekori YA: Mast cells. Physiol Rev. 77:1033–1079. 1997.PubMed/NCBI
29	Nakazawa S, Sakanaka M, Furuta K, Natsuhara M, Takano H, Tsuchiya S, Okuno Y, Ohtsu H, Nishibori M, Thurmond RL, et al: Histamine synthesis is required for granule maturation in murine mast cells. Eur J Immunol. 44:204–214. 2014. View Article : Google Scholar : PubMed/NCBI
30	Hirai S, Ohyane C, Kim YI, Lin S, Goto T, Takahashi N, Kim CS, Kang J, Yu R and Kawada T: Involvement of mast cells in adipose tissue fibrosis. Am J Physiol Endocrinol Metab. 306:E247–E255. 2014. View Article : Google Scholar : PubMed/NCBI
31	Liu ZQ, Song JP, Liu X, Jiang J, Chen X, Yang L, Hu T, Zheng PY, Liu ZG and Yang PC: Mast cell-derived serine proteinase regulates T helper 2 polarization. Sci Rep. 4:46492014. View Article : Google Scholar : PubMed/NCBI
32	McNeil HP, Shin K, Campbell IK, Wicks IP, Adachi R, Lee DM and Stevens RL: The mouse mast cell-restricted tetramer-forming tryptases mouse mast cell protease 6 and mouse mast cell protease 7 are critical mediators in inflammatory arthritis. Arthritis Rheum. 58:2338–2346. 2008. View Article : Google Scholar : PubMed/NCBI
33	Shin K, Nigrovic PA, Crish J, Boilard E, McNeil HP, Larabee KS, Adachi R, Gurish MF, Gobezie R, Stevens RL and Lee DM: Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. J Immunol. 182:647–656. 2009. View Article : Google Scholar : PubMed/NCBI
34	Hamilton MJ, Sinnamon MJ, Lyng GD, Glickman JN, Wang X, Xing W, Krilis SA, Blumberg RS, Adachi R, Lee DM and Stevens RL: Essential role for mast cell tryptase in acute experimental colitis. Proc Natl Acad Sci USA. 108:290–295. 2011. View Article : Google Scholar : PubMed/NCBI